Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, COSMOS Pharmaceutical's Enterprise Value is 円547,651 Mil.
COSMOS Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was 円34,553 Mil. Therefore, COSMOS Pharmaceutical's EV-to-EBIT ratio for today is 15.85.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, COSMOS Pharmaceutical's Enterprise Value is 円547,651 Mil.
COSMOS Pharmaceutical's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was 円34,553 Mil. Therefore, COSMOS Pharmaceutical's EV-to-EBITDA ratio for today is 15.85.
COSMOS Pharmaceutical Enterprise Value Historical Data
The historical data trend for COSMOS Pharmaceutical's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of COSMOS Pharmaceutical's Enterprise Value
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical's Enterprise Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Enterprise Value distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Enterprise Value falls into.
COSMOS Pharmaceutical Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
COSMOS Pharmaceutical's Enterprise Value for the fiscal year that ended in May. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (TSE:3349) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
COSMOS Pharmaceutical's current Enterprise Value is 円547,651 Mil.
COSMOS Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円34,553 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
COSMOS Pharmaceutical's EV-to-EBITDA for today is:
COSMOS Pharmaceutical's current Enterprise Value is 円547,651 Mil.
COSMOS Pharmaceutical's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円34,553 Mil.
COSMOS Pharmaceutical's current Enterprise Value is 円547,651 Mil.
COSMOS Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円936,706 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Enterprise Value Related Terms
Thank you for viewing the detailed overview of COSMOS Pharmaceutical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
COSMOS Pharmaceutical (TSE:3349) Business Description
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:3349 has been successfully added to your 